Notice of Intent to issue a Sole Source Award to Procure and Deliver Lateral Flow Test Results from Persons Administered Integrase Inhibitor-based Long-acting Pre-Exposure Prophylaxis (PrEP)
75D30126Q79102 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) solicitation, performed in Dallas, TX, with responses due 2026-07-23. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The Centers for Disease Control and Prevention (CDC), Division of HIV Prevention requires an HIV care clinic within a public health network with a clientele of at least 50 persons on injectable cabotegravir long-acting (CAB-LA) (Apretude) pre-exposure prophylaxis (PrEP) for over 6 months. CAB-LA upt
Comparable recent awards in RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| VEXTERRA GROUP LLC | $1000.0B | 589 | 2024-09-30 |
| A3 MISSIONS, LLC | $1000.0B | 579 | 2024-09-30 |
| R & K ENTERPRISE SOLUTIONS INC | $1000.0B | 579 | 2024-09-30 |
| IRON EAGLEX, INC. | $1000.0B | 584 | 2024-09-30 |
| DENOVO SOLUTIONS LLC | $1000.0B | 579 | 2024-09-30 |
Explore the market
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.